Salmonella is a major cause of foodborne illness in the United States, and antimicrobial-resistant strains pose a serious threat to public health. We used Bayesian hierarchical models of culture-confirmed infections during 2004-2016 from 2 Centers for Disease Control and Prevention surveillance systems to estimate changes in the national incidence of resistant nontyphoidal Salmonella infections. Extrapolating to the United States population and accounting for unreported infections, we estimated a 40% increase in the annual incidence of infections with clinically important resistance (resistance to ampicillin or ceftriaxone or nonsusceptibility to ciprofloxacin) during 2015-2016 (≈222,000 infections) compared with 2004-2008 (≈159,000 infections). Changes in the incidence of resistance varied by serotype. Serotypes I 4,[5],12:i:- and Enteritidis were responsible for two thirds of the increased incidence of clinically important resistance during 2015-2016. Ciprofloxacin-nonsusceptible infections accounted for more than half of the increase. These estimates can help in setting targets and priorities for prevention.
CITATION STYLE
Medalla, F., Gu, W., Friedman, C. R., Judd, M., Folster, J., Griffin, P. M., & Hoekstra, R. M. (2021). Increased incidence of antimicrobial-resistant nontyphoidal salmonella infections, United States, 2004-2016. Emerging Infectious Diseases, 27(6), 1662–1672. https://doi.org/10.3201/eid2706.204486
Mendeley helps you to discover research relevant for your work.